Angela Vogel, a nurse practitioner and founder of Top Form Care, discusses her journey from hospitalist burnout to launching a personalized
medicine clinic focused on weight loss, hormone replacement therapy, and functional health. Starting in July 2022 as a telehealth-only practice, Top Form Care has expanded to include in-person services across multiple states. Vogel emphasizes the importance of comprehensive patient care, extended consultation times (60-90 minutes), and addressing root causes of symptoms rather than treating isolated complaints. The conversation covers misconceptions about GLP medications, the Women's Health Initiative study's impact on hormone therapy prescribing, recent FDA removal of black box warnings on bioidentical hormones, and the clinic's distinctive approach of employing providers who have personally experienced the health challenges their patients face.

Episode Highlights
00:02:15: Angela Vogel explains her transition from hospital-based nursing to founding Top Form Care after COVID-related burnout,
inspired by personal weight loss success with GLP medications.
00:05:30: Vogel describes the clinic's evolution from weight loss focus to comprehensive functional health, including hormone replacement
therapy and nutritional assessment.
00:08:45: Discussion of the cash-based business model allowing 60-90 minute consultations versus typical 15-minute insurance-constrained
primary care visits.
00:12:20: Vogel addresses the 2002 Women's Health Initiative study that sparked widespread fear about hormone therapy, noting the study
used synthetic hormones and older patients than ideal candidates.
00:16:10: Explanation of FDA's 2025 removal of most black box warnings on bioidentical hormone therapy, with endometrial cancer warning
remaining only for unopposed estrogen.
00:19:45: Clarification that testosterone does not cause prostate cancer, debunking an 80-year-old myth originating from researcher Huggins.
00:24:30: Vogel outlines the patient journey at Top Form Care, including initial lab panels, lab interpretation visits, comprehensive
consultations, and ongoing nurse check-ins.
00:28:15: Description of staff support systems including daily educational emails, regular follow-up visits every 2-3 months, and betweenvisit
support at no additional cost.

Key Takeaways
Personalized medicine requires extended time with patients to understand their complete health picture, not just isolated symptoms or lab
values within "normal" ranges.
Media sensationalism of medical research can create lasting harm to standard of care; the 2002 Women's Health Initiative study's headlines
overshadowed important methodological limitations and led to decades of unnecessary hormone therapy avoidance.
Bioidentical hormones differ significantly from synthetic hormones used in older studies; current evidence supports appropriately prescribed
bioidentical hormone therapy has no increased risk of breast cancer, cardiovascular disease, or blood clots.
Provider credibility and empathy increase when clinicians have personally navigated the same health challenges as their patients, creating
better understanding of patient concerns and treatment nuances.
Ongoing patient support through check-ins, education, and accessible follow-up care significantly improves treatment adherence and
outcomes compared to single-visit consultation models.

Quotable Moments
"Nobody's ever sat down and listened to me like this before." — Patient feedback on the consultation experience at Top Form Care
"For every person that had an awful experience, there are 100 people who have had an awesome experience. They just don't write about it
because there's a little bit of shame still around obesity treatment."
"The ideal patient for women would be someone under 60 years old who is less than 10 years from menopause. So that's your like ideal
patient to start on hormone therapy."
"Most of us have been on whatever journey that you're on. I mean, most of us have been each other's patients."
"Testosterone does not cause prostate cancer. There's a theoretical risk that it could kind of accelerate it if you already have it. But people still
think that it will cause prostate cancer."